Dabur Pharma gets USFDA approval for selling Mitoxantrone

A board to discuss the Multiple Sclerosis modifying drug Novantrone

Dabur Pharma gets USFDA approval for selling Mitoxantrone

Postby rainer » Tue May 20, 2008 3:42 pm

Dabur Pharma Ltd's oncology unit has informed that the company has received the approval from US Food and Drug Administrator (USFDA) for selling 'Mitoxantrone Hydrochloride in various strengths’.

Dabur Pharma Ltd operates in Europe and other overseas markets through its fully-owned subsidiary, Dabur Oncology Plc.

The drug is indicated for reducing neurologic disability and /or the frequency of clinical relapses in patients with secondary chronic progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis (i.e., patients whose neurologic status is significantly abnormal between relapses).

User avatar
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 4:00 pm


Return to Novantrone


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service